Telerehabilitation Approaches in Chronic Obstructive Pulmonary Patients

COPD Clinical Trial

Official title:

Comparison of the Effectiveness of Different Telerehabilitation Approaches in Chronic Obstructive Pulmonary Patients

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04694729
• Other study ID #: TeleCOPD
• Status: Recruiting
• Phase: N/A
• Start date: January 1, 2021
• Est. completion date: December 2021

Study information

• Verified date: January 2021
• Source: Saglik Bilimleri Universitesi
• Contact: Nursima Bulut Physiotherapist
• Phone: 2163463636
• Email: bltnursima[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Pulmonary rehabilitation (PR) is a first-line management strategy in chronic obstructive pulmonary patients (COPD) as it reduces shortness of breath, increases exercise capacity, and improves health-related quality of life. However, 8-50% of patients referred to PR do not participate at all, while 10-32% of those who start do not complete the program. Barriers to participation and completion include difficulty in accessing the program, poor mobility, lack of transport, and travel costs. Telerehabilitation is defined as the provision of rehabilitation services through telecommunication technology, including telephone, internet and video conference communications between the patient and the healthcare provider. Different technologies (from phone to video conferencing) have been tested in patients with COPD to enhance daily activities, exercise training and walking prescription. All of them showed positive effects on exercise tolerance, dyspnea, physical activity and quality of life. However, there is no study about which telerehabilitation program is more effective on COPD patients. The aim of this study is to investigate which telerehabilitation approach is more effective in COPD.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 54
• Est. completion date: December 2021
• Est. primary completion date: March 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Being diagnosed with COPD (FEV1 / FVC <70% in the stable phase of the disease)
• Age > 18 years old
• Have the ability to use a smartphone

Exclusion Criteria:

• Musculoskeletal disorders that limit exercise
• Dizziness, significant sensory or motor impairments, dementia or terminal illnesses that prevent education
• Serious comorbidities such as unstable heart disease, irregular diabetes, known malignant disease, any other disease that makes the patient unsuitable for participation in the study.
• Incompatible patient
• Severe vision or hearing impairment
• Unwillingness or inability to follow the protocol
• Have had a COPD exacerbation in the previous 6 weeks

Related Conditions & MeSH terms

• COPD
• Telerehabilitation

Intervention

Other:
• videoconference-based
Exercises will be done 3 days a week for 6 weeks, with the help of a physiotherapist via video conference.
• video-based
The exercise video will be sent to the patients and they will do it 3 days a week for 6 weeks. The subjects will be asked to keep an exercise diary and the status of the diaries will be followed by calling once a week.

Locations

Country	Name	City	State
Turkey	Istanbul Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital	Istanbul

Sponsors (1)

Lead Sponsor	Collaborator
Saglik Bilimleri Universitesi

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	6 minute walk test(6MWT)		6 week
Primary	Pulmonary function testing		6 week
Secondary	30-Second Chair Stand Test		6 week
Secondary	Time Up and Go Test		6 week
Secondary	Copd Assessment Test		6 week
Secondary	St George's Respiratory Questionnaire		6 week
Secondary	Hospital Anxiety and Depression Scale		6 week
Secondary	Medical Research Council Scale		6 week
Secondary	Short Physical Performance Battery		6 week
Secondary	International Physical Activity Questionnaire-Short Form		6 week
Secondary	Static Lung Volumes		6 week